The Canadian Nationwide Advisory Committee on Immunization (NACI) isn’t recommending the newly authorized COVID-19 vaccine from AstraZeneca be used on individuals aged 65 or older.
Based on the NACI web site, that is “as a consequence of restricted info on the efficacy of this vaccine on this age group at the moment.”
[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]
Nonetheless, the company mentioned the vaccine has “demonstrated a median efficacy of roughly 62 per cent in these aged 18-64 years of age.”
The vaccine acquired approval from Well being Canada on Friday.
NACI mentioned it ought to be delivered in two doses 4 to 12 weeks aside.
Well being Canada approves Oxford-AstraZeneca’s COVID-19 vaccine
It turned the third vaccine to obtain regulatory approval in Canada, becoming a member of ones from Moderna and Pfizer-BioNTech.
Canada has ordered 24 million doses of the AstraZeneca vaccine.
-Extra to come back..
View hyperlink »
© 2021 World Information, a division of Corus Leisure Inc.